Risk minimisation material: Kymriah (tisagenlecleucel) Healthcare Professional Training -

Risk minimisation material: Kymriah (tisagenlecleucel) Healthcare Professional Training
Information type: Safety alerts
Source: Novartis
Specialities: Cancers | Haematological disorders
Summary
This guide aims to educate healthcare professionals about the risk factors, monitoring and management of cytokine release syndrome and serious neurological reactions; potential adverse reactions to treatment.
UKMi comment

Separately, a patient alert card, patient educational leaflet, and a pharmacy training guide have been produced.
Related links: Patient alert card:Patient educational leaflet:Pharmacy Training: